The health and life sciences sector is growing so quickly in Rhode Island that the Milken Institute predicts that activity in the sector will triple by 2014. The analysts attribute Rhode Island’s success to three key factors: location, resources and talent.
Rhode Island is home to a diverse and collaborative peer cluster of life science institutions and companies, including companies in drug manufacturing, basic research, biomedical devices, cell line development, bio-nanotechnology, biomedical textiles and facility development.
The Rhode Island Science and Technology Advisory Council (STAC) promotes Rhode Island’s academic and commercial research institutions, entrepreneurship and new company creation, and programs that enable innovation across the public and private sectors. In 2007, STAC launched a collaborative research award program that annually provides $1.5 million in research funding. STAC also launched an effort to strengthen research at the University of Rhode Island, and introduced a new tax credit that rewards entrepreneurs and investors supporting Rhode Island-based innovation companies.
RIEDC offers health and life sciences companies access to a portfolio of R&D tax credits, financing programs and support services including:
Dr. Dianne Ritter